North Stonington, CT, United States of America

George Joseph Quallich

This inventor holds 33 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Chiral Technologies Europe. Active years: 1988-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Joseph Quallich. Retrieved from https://idiyas.com/inventor/george-joseph-quallich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 84.8

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 178(Granted Patents)

Location History:

Stonington, CT (US) (1995)
North Stonington, CT (US) (1988 - 2014)
Venice, FL (US) (2015)

Company Filing History:

Chiral Technologies Europe

patent

Years Active: 1988-2015

Loading Chart...

Areas of Expertise:

Atorvastatin

Sertraline Salts

Chiral Intermediates

Optical Resolution

Enantioselective Catalysts

Polymorphs

Therapeutic Compounds

Apo B-Secretion

Cyclic Thioamides

Biphenyl Amides

Pyrrole Amides

3-Bromo-5-Chloro-Pyridines

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9056831 - Process for forming amorphous atorvastatin (2015-06-16),

2. 8686163 - Process for forming amorphous atorvastatin (2014-04-01),

3. 8258315 - Process for forming amorphous atorvastatin (2012-09-04),

4. 7094930 - Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof (2006-08-22),

5. 7038061 - Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-(2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl)-ethylpyrrolidine (2006-05-02),

6. 6825193 - Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof (2004-11-30),

7. 6794388 - Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof (2004-09-21),

8. 6444854 - Process for the production of enantiomerically pure or optically enriched sertraline-tetralone using continuous chromatography (2002-09-03),

9. 6388127 - Process for preparing cyclic thioamides (2002-05-14),

10. 6387925 - Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions (2002-05-14),

11. 6262272 - Method of synthesis of pyrrole amides (2001-07-17),

12. 6255320 - Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions (2001-07-03),

13. 6121283 - Apo B-secretion/MTP inhibitory amides (2000-09-19),

14. 6037505 - Enantioselective oxazaborolidine catalysts (2000-03-14),

15. 6005133 - Enantioselective oxazaborolidine catalysts (1999-12-21),

As a client interested in innovations and inventors, here is an article about the accomplished inventor, George Joseph Quallich.

Title: The Innovative Journey of George Joseph Quallich

Introduction: George Joseph Quallich, a prolific inventor based in North Stonington, CT, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 33 patents.

Latest Patents: Among his recent patents is the groundbreaking 'Process for forming amorphous atorvastatin.' This novel process involves dissolving atorvastatin in various solvents and utilizing freeze-drying techniques to produce the desired amorphous atorvastatin formulation.

Career Highlights: George Joseph Quallich has honed his expertise working with prestigious pharmaceutical companies like Pfizer Corporation and Chiral Technologies Europe. His innovative approaches have led to advancements in drug formulation and development.

Collaborations: Throughout his career, George has collaborated closely with noteworthy industry peers, including Lewin Theophilus Wint and George Chang. These collaborations have fostered the exchange of ideas and the development of cutting-edge pharmaceutical solutions.

Conclusion: In conclusion, George Joseph Quallich's pioneering work in the pharmaceutical sector stands as a testament to his dedication to innovation and scientific excellence. His patents and contributions continue to shape the landscape of pharmaceutical research and development, inspiring future generations of inventors and innovators.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]